Autopsy report · NCT02057523

Acthar as Rescue Therapy for Transplant Glomerulopathy in Kidney Transplant Recipients

“Unable to enroll patients, no longer at institution.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 7 months before it started.
• Ran for about 1 year before it stopped.
• 2 participants enrolled.
• Results were posted on the registry 5 years after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

University of Illinois at Chicago

Sponsor type

University, hospital or other

Conditions

Proteinuria; Transplant Glomerulopathy

Interventions

Acthar

Participants

2

Sites

1

Countries

United States

Trials that died the same way

• Comparison of Three Approaches of Electrode Placement to Detect Changes in Motor Evoked Potentials During Spine Surgery
  “Unable to enroll patients.” (89% match in meaning)
• Systemic Rapamycin (Sirolimus) to Prevent In-Stent Restenosis Following Pulmonary Artery Stent Placement
  “Unable to enroll appropriate patients” (82% match in meaning)
• Pharmacokinetic Study of Recombinant AT III in Neonates Undergoing ECMO
  “Unable to enroll patients into study.” (80% match in meaning)
• Discharge Counseling and Medication Therapy Management (MTM) Services After Discharge for Heart Failure Patients
  “Unable to enroll and study intended patient population.” (79% match in meaning)
• A Randomized, Prospective Clinical Trial of Immediate Flap Closure Versus Wound Care for Management of Late-stage Pressure Ulcers
  “We have not been able to enroll patients.” (79% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.